INTEREST workshop – Lilongwe

Treatment Optimisation Community Meeting

Date: 15 May 2017
Venue: Golden Peacock Hotel, Plot No 13/97, Area 13, Lilongwe, Malawi

1 day training, advocacy and strategy meeting before 11th INTEREST Workshop
Facilitators: Polly Clayden and Kenly Sikwese

Agenda

 

8.00 – 8.30

Arrival and coffee

Aims of the day and introductions – Kenly/Polly

8.30 – 10.30 Country feedback – TO initiatives since Yaoundé meeting
10.30 – 11.00 BREAK
11.00- 12.00 Update on the ADVANCE trial – Francois Venter, Wits RHI
12.00 – 12.30 Community mobilisation on the ADVANCE trial by TAC – Luckyboy Mkhondwane
12.30 – 13.00 CHAI CAB update – Kenly
13.00 – 14.00 LUNCH
14.00 – 15.00 CHAI in-country update
15.00 – 15.30 ART optimisation for Children
15.30 – 15.45 BREAK
15.45 – 16.15 Pipeline drugs – Francois Venter, Wits RHI
16.15 – 17.15 Andrew Hill presentations:
1. Universal access- HIV and beyond
2. Safety of new antiretrovirals
17.15 – 17.30 Next steps
18.00 Community dinner/reception

Background reading for TO meeting:

  1. When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank

This is a review to discuss barriers and opportunities for the introduction of new antiretrovirals into national treatment programmes in low-income and middle-income countries to support further treatment scale-up. Invitees to a WHO Think Tank in February 2017 evaluated recently published results.

  1. Generics – the facts: Andrew Hill

Andrew Hill’s presentation at the BHIVA Spring conference 2017. He discusses the new era of generic HIV drugs that are WHO approved, bioequivalent at low cost. Shouldn’t the NHS consider buying these?

The slides are here:      The podcast is here:

  1. Fit for Purpose (July 2017)

The online version of FfP is here

Read full INTEREST meeting report here.

Edit
Published: September 25, 2017
Last edited: September 26, 2017